|
WO2020023767A1
|
|
Targeting micro-rnas for exosomal delivery or cellular retention
|
|
WO2019207553A2
|
|
Methods and compositions relating to lipokines for treating metabolic disorders
|
|
WO2018160534A1
|
|
Protection of beta cells from immune attack
|
|
WO2018142379A1
|
|
Methods and compositions for treating metabolic disorders
|
|
WO2018089901A2
|
|
Exosome delivery system
|
|
WO2018026899A1
|
|
Methods and compositions for treating hypoglycemia
|
|
WO2017190003A1
|
|
Compositions and method for treating and preventing end stage renal disease
|
|
WO2017062363A1
|
|
Methods of use of betatrophin
|
|
WO2016196895A1
|
|
Methods amd compositions for promoting thermogenic potential
|
|
EP3294332A1
|
|
Retinol-binding protein 3 (rbp3) as a protective factor in non-diabetic retinal degeneration
|
|
US2018066327A1
|
|
Methods to Accelerate Wound Healing in Diabetic Subjects
|
|
WO2016089694A1
|
|
Method and system for determining insulin dosing errors
|
|
US2017173114A1
|
|
Methods and compositions for induction of ucp1 expression
|
|
US2017177825A1
|
|
Determining a level of hypoglycemic unawareness displayed by a patient
|
|
US2015056173A1
|
|
Beta cell growth and differentiation
|
|
WO2014201314A1
|
|
Microrna and uses in brown fat differentiation
|
|
US2014271694A1
|
|
Antigen-specific methods of diagnosing and/or treating myocarditis or inflammatory cardiomyopathy
|
|
WO2014137997A1
|
|
Exercise-regulated adipokines as therapy for diabetes management
|
|
WO2014039654A1
|
|
Isolation and characterization of muscle regenerating cells
|
|
WO2014018851A1
|
|
Predicting and treating diabetic complications
|
